BioNTech Sues Moderna for Patent Infringement Over COVID Shots February 20, 2026 German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging that Moderna’s COVID-19 vaccine mNEXSPIKE infringes a...
Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties December 27, 2024 BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania...
BioNTech Faces First German Lawsuit Over Alleged COVID-19 Vaccine Side Effects June 12, 2023 By Ludwig Burger and Patricia Weiss BioNTech will go to court on Monday to defend itself against a lawsuit from a German woman who is seeking...
Pfizer-BioNTech Seek FDA Full Approval for Authorized COVID-19 Vaccine May 7, 2021 By Ankur Banerjee Pfizer Inc. and German partner BioNTech SA said on Friday they have started an application process with the U.S. Food...
German Vaccine Maker Says Waivers for Vaccines Not Right Approach April 28, 2021 By Douglas Busvine The granting of intellectual property waivers is not the right way to increase output of COVID-19 vaccines, the founder of...
Pfizer Vaccine Faces Some Storage, Production, Snowstorm Challenges December 16, 2020 By Rebecca Spalding and Carl O'Donnell The first days of Pfizer Inc.’s COVID-19 vaccine rollout have seen unexpected hitches including some vaccines being stored at excessively...
FDA Expected to Quickly Approve Pfizer’s COVID Vaccine December 11, 2020 The U.S. Food and Drug Administration said on Friday it was working rapidly to issue an emergency use authorization for...
Pfizer Reports 95% Success Rate in COVID-19 Vaccine Final Trial November 18, 2020 By Michael Erman Final results from Pfizer Inc.’s COVID-19 vaccine trial showed its shot had a 95% success rate and two months of...